Trump Taps Former Lilly President To Lead HHS, Vowing Azar Will Lower Drug Prices -- But Dems Want Commitment

November 13, 2017 at 12:16 PM
President Donald Trump announced Monday (Nov. 13) via tweet the nomination of Alex Azar to lead HHS, saying the former Lilly president "will be a star for better healthcare and lower drug prices!" But Senate Finance ranking Democrat Ron Wyden (OR) said he will seek Azar's commitment to lowering drug prices during the upcoming confirmation process, and will also seek assurances that the HHS nominee will implement the Affordable Care Act, which the Trump administration has tried to unravel. Inside...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.